Vertiv (VRT): It Beat, It Raised, It Fell 17% — And Nobody Asked Where the Backlog Went

Vertiv Holdings Co (VRT) Q2 2026 — Vertiv (VRT) reported Q2 2026 (quarter ended June 30) on July 29. Adjusted diluted EPS was $1.52 (+60% y/y) against a ~$1.43 consensus — a clear beat. Adjusted operating profit rose 51% to $738M, adjusted operating margin expanded 410 bps to 22.6%, operating cash flow rose 241% to $1,100M and adjusted free cash flow rose 234% to $925M. Net sales of $3,274M grew 24% (18% organic, 5% M&A, 1% FX) but landed ~$107M below the ~$3,381M consensus and ~$76M below Vertiv's own guidance midpoint. Management raised FY2026 across the board: revenue to $14,000M midpoint (+$250M), adjusted operating profit to $3,325M (+$125M), adjusted EPS to $6.70 (+$0.35) and adjusted free cash flow to $2,500M (+$300M). The stock still fell 17.3% on the print, from $269.56 to $223.04, and trades near $229 today. Our DCF lands at ~$205. Our call: HOLD, 3/5. A quarter where profit, margin, cash flow and guidance all went up — and the stock lost roughly $17.9 billion of market value in one session over a $107 million revenue shortfall. That is 167 dollars of market cap destroyed per dollar missed, which tells you the market was not pricing the quarter; it was repricing the trajectory. Vertiv blamed the miss on 'temporary supply chain congestion and multi-phased project execution' — timing, not demand. That claim is testable: backlog, book-to-bill and organic orders growth would settle it in one line. We read all three primary documents (the 8-K earnings release, the results presentation, and the 10-Q) and none of them disclose backlog, book-to-bill or orders growth. Two quarters earlier Vertiv led its release with a $15.0B backlog, a ~2.9x book-to-bill and 252% organic orders growth. Those metrics went dark in exactly the quarter they were needed. What Vertiv cannot hide is the audited balance sheet — and it supports management: deferred revenue (customer cash paid for undelivered equipment) went from $1,814.7M in December to $3,633.7M in June, with $1,171.5M added in Q2 alone; inventories rose ~$1,066M; capex tripled to $173M and is going to the high end at ~4% of sales. Nobody raises four guidance numbers into decelerating demand. But being right about the quarter does not make the stock cheap: the FY guide now implies a Q4 of roughly $4,326M, up about 50% year over year — the largest quarter in company history, an acceleration, from the same operations that just slipped. EMEA is down 14.8% organically in the first half. At ~34x FY26 adjusted EPS and a 2.8% free-cash-flow yield, our DCF says ~$205 vs $229 today. THE CALL: HOLD (3/5, THE MARKET WAS RIGHT TO SELL AND WRONG ABOUT WHY — A GREAT BUSINESS WITH NO MARGIN OF SAFETY) — base-case value ~$205.00 vs ~$229.05 today. What to watch: Q3 revenue landing inside the $3,650M-$3,850M guide (the single cleanest test of the timing explanation); EMEA actually returning to organic growth in H2 after -2.4% in Q2 and -14.8% in H1; deferred revenue continuing to climb, since customer prepayments are the pillar the whole timing argument rests on; and Vertiv putting backlog and book-to-bill back into the earnings release, which costs management nothing and would restore the most credibility. The risks: a second consecutive revenue slip, any trim to the implied ~50%-growth Q4, EMEA staying negative, and a multiple that still assumes an uninterrupted AI capex cycle. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.